BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37671550)

  • 1. Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review.
    Niriella MA; Dassanayake U; de Silva HJ
    Expert Rev Gastroenterol Hepatol; 2023; 17(9):913-919. PubMed ID: 37671550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
    Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
    Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatocellular carcinoma].
    Semela D; Heim M
    Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of HCC.
    de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
    J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective.
    Hui RW; Mak LY; Cheung TT; Lee VH; Seto WK; Yuen MF
    Clin Mol Hepatol; 2023 Apr; 29(2):217-229. PubMed ID: 36577426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective.
    Su TH; Wu CH; Liu TH; Ho CM; Liu CJ
    Clin Mol Hepatol; 2023 Apr; 29(2):230-241. PubMed ID: 36710607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New concepts in the treatment of hepatocellular carcinoma.
    Sidali S; Trépo E; Sutter O; Nault JC
    United European Gastroenterol J; 2022 Sep; 10(7):765-774. PubMed ID: 35975347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapies for hepatocellular carcinoma: a critical view of the evidence.
    Villanueva A; Hernandez-Gea V; Llovet JM
    Nat Rev Gastroenterol Hepatol; 2013 Jan; 10(1):34-42. PubMed ID: 23147664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress.
    Brown ZJ; Hewitt DB; Pawlik TM
    Expert Opin Investig Drugs; 2022 Apr; 31(4):379-391. PubMed ID: 34788184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of hepatocellular cancer.
    Rampone B; Schiavone B; Confuorto G
    Curr Oncol Rep; 2010 May; 12(3):186-92. PubMed ID: 20425078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventional treatment for unresectable hepatocellular carcinoma.
    Murata S; Mine T; Sugihara F; Yasui D; Yamaguchi H; Ueda T; Onozawa S; Kumita S
    World J Gastroenterol; 2014 Oct; 20(37):13453-65. PubMed ID: 25309076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update.
    Wen N; Cai Y; Li F; Ye H; Tang W; Song P; Cheng N
    Biosci Trends; 2022 Mar; 16(1):20-30. PubMed ID: 35197399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personalized healthcare in hepatocellular carcinoma. Multi-society Italian position paper.].
    Trevisani F; Garuti F; Neri A
    Recenti Prog Med; 2018 Jan; 109(1):38-45. PubMed ID: 29451521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing localized unresectable hepatocellular carcinoma.
    Narang-Master J; Rizzolo D
    JAAPA; 2015 Jan; 28(1):27-34. PubMed ID: 25486501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment of hepatocellular carcinoma.
    Graf D; Vallböhmer D; Knoefel WT; Kröpil P; Antoch G; Sagir A; Häussinger D
    Eur J Intern Med; 2014 Jun; 25(5):430-7. PubMed ID: 24666568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the treatment of hepatocellular carcinoma.
    Padhya KT; Marrero JA; Singal AG
    Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective.
    Koga H; Iwamoto H; Suzuki H; Shimose S; Nakano M; Kawaguchi T
    Clin Mol Hepatol; 2023 Apr; 29(2):242-251. PubMed ID: 36941079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.